You start at a low dose and escalate gradually to minimize side effects, and you stay at your peak dose until you reach your target weight or plateau
NHS access for weight management is more restricted
Materials and methods: The study included 67,140 pairs of 1:1 propensity score (PS) matched patients 18 years with T2D newly initiating EMPA or any dipeptidyl peptidase-4 inhibitor (DPP-4i) use from large databases/registers in Israel, Finland, Germany, Spain, Sweden, South Korea, Taiwan and Japan using an as-treated approach
Peptide therapy uses targeted amino acid chains to help support cellular communication and natural biological processes related to recovery, metabolism, hormone signaling, sleep, muscle repair, cognitive function, and healthy aging
Combine that with product upsells supplements, glucose monitors, lifestyle kits and your GLP-1 weight loss program becomes a reliable growth channel